Patent Application
App. No. 16/517,965
ANTI-IL-6 ANTIBODIES FOR THE TREATMENT OF ANEMIA
Loading inventors, assignments & file history…
Abstract
The present invention is directed to therapeutic methods using IL-6 antagonists such as anti-IL-6 antibodies and fragments thereof having binding specificity for IL-6 to prevent or treat anemia (e.g., anemia associated with chemotherapy) including persons on a treatment regimen with a drug or chemotherapy and/or radiation for cancer (e.g., head and neck cancer) that is associated with increased risk of anemia.
Claims (2)
1 . A method of treating or preventing anemia comprising administration of a composition comprising an effective amount of IL-6 antagonist.
2 - 418 . (canceled)
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Aug 14, 2020
From: H. LUNDBECK A/S
To: VITAERIS INC.
Reel/Frame 053496/0319 →